相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
882531-87-5
- 规格:
10 mM * 1 mL/1 mg/5 mg/10 mg/25 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥942.0 |
|---|---|---|---|
| 规格: | 1 mg | 产品价格: | ¥520.0 |
| 规格: | 5 mg | 产品价格: | ¥1200.0 |
| 规格: | 10 mg | 产品价格: | ¥1990.0 |
| 规格: | 25 mg | 产品价格: | ¥4080.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
R1530
CAS No. : 882531-87-5
MCE 国际站:R1530
产品活性:R1530 是一种高效的,具有口服活性的有丝分裂/血管生成 (mitosis/angiogenesis) 双重作用抑制剂,具有抗肿瘤和抗血管生成活性。R1530 是一种多激酶抑制剂,与 31 种激酶结合的 Kd 均小于 500 nM。R1530 抑制 VGFr2、FGFr1 作用的 IC50 分别为 10 nM 和 28 nM。R1530 可以触发细胞凋亡 (有丝分裂) 或衰老。
研究领域:Protein Tyrosine Kinase/RTK | Apoptosis
In Vitro: R1530 exhibits potent in vitro antiproliferative activity in all of the tumor cell lines ( IC50 = 0.2−3.4 μM).
R1530 inhibits the kinase activities of vascular endothelial growth factor receptor 2 (VGFr2), FGFr1 and PDGFr-β. R1530 has inhibition of VEGF and bFGF induces HUVEC proliferation ( IC50 = 49 and 118 nM).
In Vivo: R1530 (1.56, 25, and 50 mg/kg; p.o.; daily, for 28 days.) has notable antitumor activity across a broad range of human xenograft models, with minimal toxicity.
相关产品:Bioactive Compound Library Plus | Apoptosis Compound Library | Kinase Inhibitor Library | Protein Tyrosine Kinase Compound Library | Anti-Cancer Compound Library | Differentiation Inducing Compound Library | Reprogramming Compound Library | Orally Active Compound Library | Anti-Breast Cancer Compound Library | Anti-Lung Cancer Compound Library | Anti-Pancreatic Cancer Compound Library | Anti-Blood Cancer Compound Library | Anti-Obesity Compound Library | Angiogenesis-Related Compound Library | Anti-Liver Cancer Compound Library | Anti-Colorectal Cancer Compound Library | Protein-protein Interaction Inhibitor Library | Anti-Prostate Cancer Compound Library | Anti-Pulmonary Fibrosis Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Cytokine Inhibitors Library | Cell Death Library | MG-132 | Doxorubicin hydrochloride | Bafilomycin A1 | LY294002 | Tamoxifen | Paclitaxel | Y-27632 | Acetylcysteine | Angiotensin II human | 2-Deoxy-D-glucose | Staurosporine | SB-431542 | Actinomycin D | Deferoxamine mesylate | Bortezomib | 5-Fluorouracil | Trametinib | Sorafenib | Oxaliplatin | Gemcitabine | Temozolomide | Rotenone | Mdivi-1 | Elesclomol | Ruxolitinib | Decitabine | SP600125 | MK-2206 dihydrochloride | Etoposide | Monomethyl auristatin E
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验培养基中,37℃振摇过夜。 (2)接种25ml过夜培养物于500ml LB培养基,37℃振摇,至OD600 达到0.4. (3)迅速将培养物置于冰浴中30min,至充分冷却。 (4)将菌液转移至预冷的离心管中,4℃下以2500r/min离心15 min,弃培养液,回收细胞。 (5)以10ml预冷的10%甘油洗涤沉淀,低温离心,共两次。 (6)加约1ml(适量)预冷的10%甘油重悬沉淀,稀释悬液100倍,测量OD600,至稀释浓度为2-3×1010个细胞/ ml (1.0 OD600约
如下:What?这完全没有办法聚类好么,我还怎么看差异变化?把这样的热图给老板,别说文章凉了,能不能走出老板办公室都是问题。图片来源:影视截图现在的高分论文一个个华丽丽的配图,动辄 R 语言、Python…听起来就高级,笔者当年凭着中学的记忆笨笨地操作 Excel,真是苦不堪言!老板说了,要是再做不出来满意的图,就滚去刷一个月锥形瓶。于是就有小伙伴问了,没时间系统地学习编程,那种「套代码公式就能搞定 R 语言绘图,懂中文就能会的教程」,能不能给我来一份啊?答案是肯定的了,下面就跟随笔者,从作图小白一步步做个初级大触
将菌液转移至预冷的离心管中,4℃下以2500r/min离心15 min,弃培养液,回收细胞。 ² 以10ml预冷的10%甘油洗涤沉淀,低温离心,共两次。 ² 加约1ml(适量)预冷的10%甘油重悬沉淀,稀释悬液100倍,测量OD600 , 至稀释浓度为2-3×1010 个细胞/ ml (1.0 OD600 约2.5×1010 个细胞/ml)。分装,-80℃或液氮保存待用。 2 病毒骨架质粒转化大肠杆菌,扩增,纯化。 3 将1-5µl
技术资料暂无技术资料 索取技术资料

















